Wolverine Trading, LLC Corbus Pharmaceuticals Holdings, Inc. Transaction History

Wolverine Trading, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	BUY	$0.32 - $0.67 $0 - $1	2 Added 0.01%	18,377 $9,000
Q4 2021 Feb 14, 2022	SELL	$0.6 - $1.11 $5,661 - $10,473	-9,436 Reduced 33.93%	18,375 $11,000
Q3 2021 Nov 12, 2021	BUY	$1.01 - $1.82 $3,967 - $7,148	3,928 Added 16.45%	27,811 $28,000
Q1 2021 May 14, 2021	BUY	$1.27 - $3.42 $10,402 - $28,013	8,191 Added 52.2%	23,883 $44,000
Q3 2020 Nov 13, 2020	SELL	$1.5 - $9.38 $13,179 - $82,412	-8,786 Reduced 35.89%	15,692 $31,000
Q2 2020 Aug 13, 2020	BUY	$4.79 - $8.39 $5,633 - $9,866	1,176 Added 5.05%	24,478 $194,000
Q1 2020 May 11, 2020	BUY	$3.44 - $7.21 $23,209 - $48,645	6,747 Added 40.76%	23,302 $128,000
Q4 2019 Feb 12, 2020	BUY	$4.29 - $5.64 $11,655 - $15,323	2,717 Added 19.63%	16,555 $89,000
Q3 2019 Nov 14, 2019	SELL	$4.87 - $7.08 $42,291 - $61,482	-8,684 Reduced 38.56%	13,838 $69,000
Q2 2019 Aug 20, 2019	BUY	$6.6 - $7.8 $16,625 - $19,648	2,519 Added 12.59%	22,522 $156,000
Q1 2019 May 15, 2019	SELL	$5.76 - $8.95 $81,768 - $127,054	-14,196 Reduced 41.51%	20,003 $139,000
Q4 2018 Feb 14, 2019	BUY	$5.26 - $7.97 $70,589 - $106,957	13,420 Added 64.58%	34,199 $201,000
Q4 2017 Feb 14, 2018	BUY	$6.6 - $7.78 $137,141 - $161,660	20,779	20,779 $148,000

38.7K

Ticker CRBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,268,000
Market Cap $2.08B
Description
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.